Literature DB >> 10958341

Tamoxifen inhibits Ca2+ uptake by the cardiac sarcoplasmic reticulum.

M E Kargacin1, Z Ali, C A Ward, N S Pollock, G J Kargacin.   

Abstract

Ca2+ transients in isolated cardiac ventricular myocytes and the amount of Ca2+ that could be released from the sarcoplasmic reticulum (SR) in these cells by caffeine were reduced in the presence of tamoxifen. To examine the effects of tamoxifen on the cardiac muscle SR directly, isolated SR vesicles and fluorimetry methods were used to measure the uptake of Ca2+ by the SR and the ATPase activity of the SR Ca2+ pump. SR Ca2+ uptake was inhibited by tamoxifen at concentrations greater than 2.4 microM. Half-maximal inhibition was seen at approximately 5 microM. Inhibition of uptake was not due to the development of a substantial tamoxifen-dependent leak of Ca2+ from the SR or to a direct inhibitory effect of tamoxifen on the ATPase activity of the SR Ca2+ pump. In addition to its effect on SR Ca2+ uptake, tamoxifen also reduced the rate at which stored Ca2+ could be released from the SR by the Ca2+ ionophore 4-bromo A23187. Our results are consistent with the hypothesis that tamoxifen inhibits an ion current that accompanies Ca2+ movement across the SR membrane. This possibility is also consistent with the known inhibitory action of tamoxifen on some types of Cl- and K+ channels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10958341     DOI: 10.1007/s004240000318

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  7 in total

1.  Epigallocatechin-3-gallate has dual, independent effects on the cardiac sarcoplasmic reticulum/endoplasmic reticulum Ca2+ ATPase.

Authors:  M E Kargacin; T L Emmett; Gary J Kargacin
Journal:  J Muscle Res Cell Motil       Date:  2011-08-05       Impact factor: 2.698

2.  Effects of anti-oestrogens and beta-estradiol on calcium uptake by cardiac sarcoplasmic reticulum.

Authors:  M L Dodds; M E Kargacin; G J Kargacin
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

3.  Inhibition of SERCA2 Ca(2+)-ATPases by Cs(+).

Authors:  Gary J Kargacin; Roozbeh Aschar-Sobbi; Margaret E Kargacin
Journal:  Pflugers Arch       Date:  2004-10-12       Impact factor: 3.657

4.  Inhibition of a cardiac sarcoplasmic reticulum chloride channel by tamoxifen.

Authors:  Sanja Beca; Evgeny Pavlov; Margaret E Kargacin; Roozbeh Aschar-Sobbi; Robert J French; Gary J Kargacin
Journal:  Pflugers Arch       Date:  2008-05-06       Impact factor: 3.657

5.  Raloxifene acutely suppresses ventricular myocyte contractility through inhibition of the L-type calcium current.

Authors:  Reginald Liew; Mark A Stagg; Kenneth T MacLeod; Peter Collins
Journal:  Br J Pharmacol       Date:  2004-03-15       Impact factor: 8.739

6.  Direct, differential effects of tamoxifen, 4-hydroxytamoxifen, and raloxifene on cardiac myocyte contractility and calcium handling.

Authors:  Michelle L Asp; Joshua J Martindale; Joseph M Metzger
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

7.  In silico elucidation of the molecular mechanism defining the adverse effect of selective estrogen receptor modulators.

Authors:  Lei Xie; Jian Wang; Philip E Bourne
Journal:  PLoS Comput Biol       Date:  2007-09-26       Impact factor: 4.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.